Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Caraci

Showing results (31-40 of 251) with videos related to

Pageof 26
Sort By:
Pharmaceuticals (Basel, Switzerland)|December 16, 2020
Antioxidant Properties of Second-Generation Antipsychotics: Focus on MicrogliaGiuseppe Caruso, Margherita Grasso, Annamaria Fidilio, et al.
Rivista Di Psichiatria|December 22, 2020
[Personalized treatment of depression phenotypes: role of trazodone in depression with insomnia]Raffaele Antonelli Incalzi, Filippo Caraci, Alessandro Cuomo, et al.
Schizophrenia (Heidelberg, Germany)|April 8, 2026
Dose reduction and discontinuation of antipsychotics in psychotic disorders: a systematic review of qualitative studies and meta-synthesisSofia Francesca Aprile, Alessandro Rodolico, Antonio Munafò, et al.
Frontiers in Pharmacology|October 2, 2019
Rescue of Noradrenergic System as a Novel Pharmacological Strategy in the Treatment of Chronic Pain: Focus on Microglia ActivationFilippo Caraci, Sara Merlo, Filippo Drago, et al.
Expert Opinion on Drug Discovery|June 1, 2021
How can we accelerate COVID-19 vaccine discovery?Giulia Russo, Valentina Di Salvatore, Filippo Caraci, et al.
Vitamins and Hormones|June 16, 2004
Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxisAlfredo Bianchi, Salvatore Salomone, Filippo Caraci, et al.
Molecular Neurobiology|August 14, 2012
Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's diseaseMaria Laura Giuffrida, Flora Tomasello, Filippo Caraci, et al.
Drug Safety - Case Reports|October 18, 2016
Propranolol: Effectiveness and Failure in Infantile Cutaneous HemangiomasAndrea Domenico Praticò, Filippo Caraci, Piero Pavone, et al.
CNS & Neurological Disorders Drug Targets|September 18, 2013
Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers?Filippo Caraci, Sabrina Castellano, Salvatore Salomone, et al.
Brain Sciences|June 28, 2023
Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs-A ReviewAntonino Messina, Carmen Concerto, Alessandro Rodolico, et al.
Pageof 26

Showing results (31-40 of 251) with videos related to

Sort By:
Pageof 26
Pharmaceuticals (Basel, Switzerland)|December 16, 2020
Antioxidant Properties of Second-Generation Antipsychotics: Focus on MicrogliaGiuseppe Caruso, Margherita Grasso, Annamaria Fidilio, et al.
Rivista Di Psichiatria|December 22, 2020
[Personalized treatment of depression phenotypes: role of trazodone in depression with insomnia]Raffaele Antonelli Incalzi, Filippo Caraci, Alessandro Cuomo, et al.
Schizophrenia (Heidelberg, Germany)|April 8, 2026
Dose reduction and discontinuation of antipsychotics in psychotic disorders: a systematic review of qualitative studies and meta-synthesisSofia Francesca Aprile, Alessandro Rodolico, Antonio Munafò, et al.
Frontiers in Pharmacology|October 2, 2019
Rescue of Noradrenergic System as a Novel Pharmacological Strategy in the Treatment of Chronic Pain: Focus on Microglia ActivationFilippo Caraci, Sara Merlo, Filippo Drago, et al.
Expert Opinion on Drug Discovery|June 1, 2021
How can we accelerate COVID-19 vaccine discovery?Giulia Russo, Valentina Di Salvatore, Filippo Caraci, et al.
Vitamins and Hormones|June 16, 2004
Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxisAlfredo Bianchi, Salvatore Salomone, Filippo Caraci, et al.
Molecular Neurobiology|August 14, 2012
Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's diseaseMaria Laura Giuffrida, Flora Tomasello, Filippo Caraci, et al.
Drug Safety - Case Reports|October 18, 2016
Propranolol: Effectiveness and Failure in Infantile Cutaneous HemangiomasAndrea Domenico Praticò, Filippo Caraci, Piero Pavone, et al.
CNS & Neurological Disorders Drug Targets|September 18, 2013
Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers?Filippo Caraci, Sabrina Castellano, Salvatore Salomone, et al.
Brain Sciences|June 28, 2023
Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs-A ReviewAntonino Messina, Carmen Concerto, Alessandro Rodolico, et al.
Pageof 26